Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-09-22-Speech-3-964"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2010-09-22"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"de"^^xsd:language2
lpv:document identification number	"en.20100922.20.3-964"2
lpv:hasSubsequent	lp_eu:2010-09-22-Speech-3-9632
lpv:speaker	lp:Andreas Mölzer2
lpv:spokenAs	substitute; AFCO (2009-07-16--2012-01-18)3 member; NA (2009-07-14--2014-06-30)3 member; AFET (2009-07-16--2012-01-18)3 member; Delegation to the EU-Ukraine Parliamentary Cooperation Committee (2009-09-16--2014-06-30)3 unknown; Freiheitliche Partei Österreichs (2009-07-14--2014-06-30)3 substitute; Delegation to the EU-Chile Joint Parliamentary Committee (2009-09-16--2014-06-30)3
lpv:translated text	"Pharmacovigilance is the name of the system for monitoring the safety of medicinal products after they have been authorised. In order to be able to guarantee patients the best possible protection, information on Adverse Drug Reactions (ADRs) should be collated from the whole of the EU quickly and with no red tape. Only in this way can quick action be taken and an assessment of the follow up made. In addition, it would be of enormous benefit to patients if they could find out about ADRs from a central location. I voted in favour of the report, as its aim is for unbureaucratic and swift action to be taken in the area of pharmacovigilance."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph